Table 2.
Hospital Management Practices in diabetic and non-diabetic patients hospitalized with NSTEMI
| Diabetic (n=1,475) % | Non-Diabetic (n=2,441) % | p-value | |
|---|---|---|---|
| Cardiac Medications | |||
| ACE-inhibitors/ARBs | 64.3 | 53.4 | <0.01 |
| Anticoagulants | 74.7 | 77.2 | 0.08 |
| Aspirin | 91.9 | 90.8 | 0.21 |
| Beta Blockers | 87.9 | 86.5 | 0.07 |
| Calcium Channel Blockers | 32.9 | 27.3 | <0.01 |
| Digoxin | 26.7 | 21.1 | <0.01 |
| Diuretics | 71.8 | 53.4 | <0.01 |
| Lipid Lowering | 65.4 | 60.0 | <0.01 |
| Diagnostic/Intervention Procedures | |||
| Cardiac Catheterization | 46.5 | 48.2 | 0.28 |
| PCI | 24.7 | 28.5 | <0.01 |
| CABG surgery | 6.5 | 5.9 | 0.44 |
*
ACE: angiotensin-converting enzyme inhibitors; ARBs: angiotensin receptor blockers; PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft